Showing results (131-140 of 163) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
Increased Foxp3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T CellsYi-Bin Chen, Yvonne A Efebera, Laura Johnston, et al.
JCI Insight|October 20, 2017
T cells expressing chimeric antigen receptor promote immune toleranceAntonio Pierini, Bettina P Iliopoulou, Heshan Peiris, et al.
The New England Journal of Medicine|September 30, 2005
Protective conditioning for acute graft-versus-host diseaseRobert Lowsky, Tsuyoshi Takahashi, Yin Ping Liu, et al.
Transplantation and Cellular Therapy|July 18, 2021
A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation TrialTessa M Andermann, Farnaz Fouladi, Fiona B Tamburini, et al.
Transplantation and Cellular Therapy|April 29, 2021
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide EraAndrew Johnsrud, Abdullah Ladha, Lori Muffly, et al.
Nature Communications|May 31, 2014
Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerancePatricia E de Almeida, Everett H Meyer, Nigel G Kooreman, et al.
Bone Marrow Transplantation|June 24, 2021
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myelomaChristopher Lemieux, Lori S Muffly, David J Iberri, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generationAnnelie E Abrahamsson, Ifat Geron, Jason Gotlib, et al.
Blood|May 8, 2012
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidenceSally Arai, Bita Sahaf, Balasubramanian Narasimhan, et al.
JCI Insight|March 4, 2020
MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitorsDominik Marschner, Martina Falk, Nora Rebeka Javorniczky, et al.
Pageof 17